Patents by Inventor Renyikun YUAN

Renyikun YUAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11865129
    Abstract: The present disclosure relates to an application of anemoside B4 in preparation of drug for treatment or prevention of psoriasis. Anemoside B4 has therapeutic effect on 5% imiquimod-induced psoriatic lesions in mice. Its possible mechanism may be inhibiting inflammation reactions, regulating immune function and inhibiting angiogenesis, and the therapeutic effect may be realized by inhibiting the release of IL-12, IL-17, IL-6 and IL-1? in skin tissue. This study of the present disclosure laid a theoretical foundation for the subsequent development of anemoside B4 into an anti-psoriasis drug of traditional Chinese medicine.
    Type: Grant
    Filed: June 2, 2022
    Date of Patent: January 9, 2024
    Assignee: GUANGXI XINHAI PHARMACEUTICAL TECHNOLOGY CO., LTD.
    Inventors: Hongwei Gao, Shilin Yang, Renyikun Yuan, Xiaoran Li
  • Publication number: 20230201230
    Abstract: The present disclosure relates to an application of anemoside B4 in preparation of drug for treatment or prevention of psoriasis. Anemoside B4 has therapeutic effect on 5% imiquimod-induced psoriatic lesions in mice. Its possible mechanism may be inhibiting inflammation reactions, regulating immune function and inhibiting angiogenesis, and the therapeutic effect may be realized by inhibiting the release of IL-12, IL-17, IL-6 and IL-1? in skin tissue. This study of the present disclosure laid a theoretical foundation for the subsequent development of anemoside B4 into an anti-psoriasis drug of traditional Chinese medicine.
    Type: Application
    Filed: June 2, 2022
    Publication date: June 29, 2023
    Inventors: Hongwei GAO, Shilin YANG, Renyikun YUAN, Xiaoran LI